About: A randomized multicentre phase II trial comparing adjuvant therapy in patients with interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival -

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A randomized multicentre phase II trial comparing adjuvant therapy in patients with interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2009 (fr) наукова стаття, опублікована в травні 2009 (uk) im Mai 2009 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q59652166-BCD491B8-4A80-4742-AF51-03F766910CF8
publication date	2009-05-26 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q59652166-CC2FE65F-22C4-417C-A4B6-412BC0662E52
language of work or name	English
exact match	wds:Q59652166-ADD892CC-C9ED-4CDE-BA9F-8E8FE55C47B5
exact match	https://scigraph.springernature.com/pub.10.1186/1471-2407-9-160
cites work	wds:Q59652166-02B8CC65-3210-4E34-AE98-9F41756197B5 wds:Q59652166-0BB7FA3D-8E32-4DF5-AA63-C417FDB0C1FE wds:Q59652166-11D35870-0110-4482-8E09-762F12F6C457 wds:Q59652166-2600D366-BBE1-4E08-AFE5-5974073FE950 wds:Q59652166-3D6AEDE8-3C33-4033-92E7-6405E289B27E wds:Q59652166-49DB35BD-25A6-4263-B0CE-DA266549BA83 wds:Q59652166-542AB68A-F164-4DCA-B9A7-4506BB51A4D6 wds:Q59652166-54D6FA95-980A-4C30-8466-3CED264BB0B7 wds:Q59652166-76C53148-549A-4D6A-99C4-36E2672B7BB5 wds:Q59652166-7EFB5034-F63B-4DF1-BEB5-7BD93FA25968 wds:Q59652166-8951F4B8-80D9-4669-BFC4-60DB9F9E99E2 wds:Q59652166-8AF5C128-0AA4-492A-8C21-4E63AF5E6596 wds:Q59652166-B82D3210-D17A-480A-8CE4-505FBD01A5A7 wds:Q59652166-C2EB7868-E0A5-43F8-99AE-997CE18E717C wds:Q59652166-E4051F63-ECC8-4E7D-841F-EBE3BDD68319 wds:Q59652166-E715E573-60E7-43CD-BAA4-6A47AC0B17B1 wds:Q59652166-EAD2FC49-8937-4B36-928A-59E69BFA68FF wds:Q59652166-EDAC7A62-B6A9-42C8-8CCB-926F39FCF681 wds:Q59652166-FE9A876F-3199-48CF-972D-0ED0B7F189F5
cites work	Cytokine therapeutics: lessons from interferon alpha Cancer statistics, 2007 Most Pancreatic Cancer Resections are R1 Resections A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer Interferon-based adjuvant chemoradiation therapy after pancreaticoduodenectomy for pancreatic adenocarcinoma Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial [S3-Guidelines "Exocrine pancreatic cancer" 2007] Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma -- CapRI: study protocol [ISRCTN62866759] Interferon-alpha restitutes the chemosensitivity in pancreatic cancer. Synergistic effects of interferon-alpha in combination with chemoradiation on human pancreatic adenocarcinoma Enhancement of radiation effects by alpha interferon in the treatment of small cell carcinoma of the lung Adjuvant interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: a single-institution phase II study Interferon-alpha in combination with chemotherapy has potent antiangiogenic properties in an orthotopic mouse model for pancreatic adenocarcinoma New techniques and agents in the adjuvant therapy of pancreatic cancer. Impact of interferon-alpha in combined chemoradioimmunotherapy for pancreatic adenocarcinoma (CapRI): first data from the immunomonitoring Immunomodulatory impact of interferon-alpha in combination with chemoradiation of pancreatic adenocarcinoma (CapRI). Interferon-alpha enhances antitumor effect of chemotherapy in an orthotopic mouse model for pancreatic adenocarcinoma
author name string	wds:Q59652166-5A896FF8-FEB9-4055-87A9-BEB51F5D30F3 wds:Q59652166-8D5B37F7-02C7-4479-B065-24AE56679730 wds:Q59652166-A363BC53-22A6-40B7-B075-B02F3DDDDBC0 wds:Q59652166-BE8C48D0-4C40-45C0-8148-E161D4DAB628 wds:Q59652166-DCD3CCF6-17C9-45F7-B23A-2ECFB34161C6 wds:Q59652166-E89DE52E-7C8F-48EC-9AEC-1EA41C7A7A50 wds:Q59652166-FDC10031-445D-4C9F-AC84-796F3C5A2BA9
author name string	Roland Schmid Thomas Seufferlein Jan Schmidt Dirk Jäger Jennifer Ose Sabine Harig Angela Märten
rdfs:label	A randomized multicentre phase II trial comparing adjuvant therapy in patients with interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - (en) A randomized multicentre phase II trial comparing adjuvant therapy in patients with interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (nl)
skos:prefLabel	A randomized multicentre phase II trial comparing adjuvant therapy in patients with interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - (en) A randomized multicentre phase II trial comparing adjuvant therapy in patients with interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (nl)
name	A randomized multicentre phase II trial comparing adjuvant therapy in patients with interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - (en) A randomized multicentre phase II trial comparing adjuvant therapy in patients with interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (nl)
author	wds:Q59652166-01A3D8A2-E05A-43A2-B1A4-D3DF6CDD741F wds:Q59652166-07405E99-2D56-48D9-AA68-D18394337227 wds:Q59652166-277B4A9F-CAF4-4609-BE17-9CB5EE6D8526 wds:Q59652166-58EED8F6-FAE0-42EC-A0A8-AF8B4323CC71 wds:Q59652166-8B05FD38-CCB7-44B0-8E72-435A1A7F2DFE wds:Q59652166-CFCDE2EB-14F1-4764-BCD7-C4304BC82960 wds:Q59652166-E88C4D23-B3E9-4EDB-996A-3BC0C1A56447
author	Markus Büchler Thomas Gress Ulrich Abel Helmut Friess Julia Mayerle Guido Adler Marc W Münter
title	wds:Q59652166-44929C56-E777-4A8D-93B7-A3FA29819BF9
title	A randomized multicentre phase II trial comparing adjuvant therapy in patients with interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival - (en)
page(s)	wds:Q59652166-16DD3116-E59E-46F5-B9AA-FABDDF7282B0
page(s)	160
instance of	wds:Q59652166-9F6FDCFB-2185-41CD-B438-1864A70B1ACB
instance of	scholarly article
main subject	wds:Q59652166-06768FCA-EA0A-498F-A389-1BBB589EB475 wds:Q59652166-94548ED6-079B-45D4-B08E-116036EA8687 wds:Q59652166-F4FEFCFC-6C39-4E3D-A145-892405DB6E55
main subject	multicenter clinical trial cisplatin phase II clinical trial
PubMed ID	wds:Q59652166-DDCDA60E-5D2D-4380-989F-35B594658922
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19470159
PubMed ID	19470159
published in	wds:Q59652166-15DCF128-D612-491A-BE8C-3F22A7B0B9F7
published in	BMC Cancer

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software